AI Analysis AI Analysis of BIOYF AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BIOYF to Watchlist?
Some Reasons Why To Add BIOYF:
  • Beat earnings estimates in 3 of the last 4 quarters
  • Healthy interest coverage ratio of 170.1x
  • High gross margin of 74.1%
PDF

BioSyent Inc. stock downgraded from Hold/Accumulate to Sell Candidate after Friday trading session
(Updated on Jul 31, 2026)

Sell candidate since Jul 31, 2026

The BioSyent Inc. stock price fell by -0.524% on the last day (Friday, 31st Jul 2026) from $10.50 to $10.44. During the last trading day the stock fluctuated 0.766% from a day low at $10.44 to a day high of $10.52. The price has been going up and down for this period, and there has been a -0.1% loss for the last 2 weeks. Volume has increased on the last day by 185 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 300 shares were bought and sold for approximately $3.13 thousand.

The stockis at the upper part of a horizontal trend and normally this may pose a good selling opportunity but a break-up through the top trend line at $10.49 will give a strong buy signal and a trend shift could be expected. Given the current horizontal trend, you can expect BioSyent Inc. stock with a 90% probability to be traded between $9.61 and $10.39 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

BIOYF Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Thursday, July 30, 2026, and so far it has fallen -0.524%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). BioSyent Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued. The BioSyent Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $10.43 and $10.21. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for BioSyent Inc. stock

BioSyent Inc. finds support from accumulated volume at $10.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.0800 between high and low, or 0.766%. For the last week the stock has had daily average volatility of 0.230%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BIOYF) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect BioSyent Inc. to open at $10.47, and during the day (based on 14 day Average True Range), to move between $10.40 and $10.48, which gives a possible trading interval of +/-$0.0820 (+/-0.79%) up or down from last closing price. If BioSyent Inc. takes out the full calculated possible swing range there will be an estimated 0.79% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $10.63 (1.82%) than the support at $10.20 (2.30%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is BioSyent Inc. stock A Buy?

BioSyent Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -2.247 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $10.47 ( 0.255%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BIOYF Performance

Trading levels for BIOYF

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 10.55 1.02%
R2 10.52 0.729%
R1 10.50 0.548%
Price 10.44
S1 10.44 -0.0373%
S2 10.42 -0.218%
S3 10.39 -0.511%

Accumulated Volume Support & Resistance Levels

Level Price
R3 10.71 2.59%
R2 10.69 2.39%
R1 10.63 1.82%
Price 10.44
S1 10.20 -2.30%
S2 9.90 -5.17%
S3 9.89 -5.27%

BIOYF Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 29, 2026 May 29, 2026 Jun 15, 2026 $0.0401 0.382%
2 Jan 29, 2026 Feb 27, 2026 Mar 13, 2026 $0.0406 0.378%
3 Nov 28, 2025 Nov 28, 2025 Dec 15, 2025 $0.0355 0.442%
4 Aug 29, 2025 Aug 29, 2025 Sep 15, 2025 $0.0359 0.408%
5 May 30, 2025 May 30, 2025 Jun 13, 2025 $0.0358 0.424%

FAQ

What is the symbol for BioSyent Inc. Stock and on which exchange is it traded?
The symbol for BioSyent Inc. is BIOYF and it is traded on the PINK (Pink Sheets).

Should I buy or sell BioSyent Inc. Stock?
BioSyent Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy BioSyent Inc. Stock?
BioSyent Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioSyent Inc. Stock.

What's the current price of BioSyent Inc. Stock?
As of the end of day on the Jul 31, 2026, the price of an BioSyent Inc. (BIOYF) share was $10.44.

What is the 52-week high and low for BioSyent Inc. Stock?
The 52-week high for BioSyent Inc. Stock is $12.00 and the 52-week low is $7.63.

What is the market capitalization of BioSyent Inc. Stock?
As of the Jul 31, 2026, the market capitalization of BioSyent Inc. is 119.416M.

When is the next earnings date for BioSyent Inc.?
The upcoming earnings date for BioSyent Inc. is Aug 25, 2026.
Click to get the best stock tips daily for free!
ABOUT BIOSYENT INC.
BioSyent
BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX 150, an oral hematinic; FeraMAX Powder, a water soluble oral iron supplement, which helps the body form red blood cells; and FeraMAX Pd Therapeutic 150 for the prevention and treatment of iron deficiency anemia. It also offers Cathejell, a ...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE